Tony R. Green

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 7 publications

The crucial role of early diagnosis for patients and the nation, understanding the costs of late-stage cancer diagnosis from a large district general hospital in England.

The crucial role of early diagnosis for patients and the nation, understanding the costs of late-stage cancer diagnosis from a large district general hospital in England.

Journal: Cost effectiveness and resource allocation : C/E

Published: May 28, 2025

From Metcalf to myeloproliferative neoplasms - a personal journey.

From Metcalf to myeloproliferative neoplasms - a personal journey.

Journal: Experimental hematology

Published: September 06, 2021

Ruxolitinib-induced defects in DNA repair cause sensitivity to PARP inhibitors in myeloproliferative neoplasms.

Ruxolitinib-induced defects in DNA repair cause sensitivity to PARP inhibitors in myeloproliferative neoplasms.

Journal: Blood

Published: May 12, 2017

Costs of haematological disease high and rising.

Costs of haematological disease high and rising.

Journal: The Lancet. Haematology

Published: June 23, 2016

The European Hematology Association Roadmap for European Hematology Research: a consensus document.

The European Hematology Association Roadmap for European Hematology Research: a consensus document.

Journal: Haematologica

Published: December 15, 2015

The evolving genomic landscape of myeloproliferative neoplasms.

The evolving genomic landscape of myeloproliferative neoplasms.

Journal: Hematology. American Society of Hematology. Education Program

Published: February 20, 2015

Age and aging in blood disorders: EHA theme of the year 2013-2014.

Age and aging in blood disorders: EHA theme of the year 2013-2014.

Journal: Haematologica

Published: June 05, 2013

Showing 1-7 of 7

Last Updated: 09/26/2026